{
    "2019-04-11": [
        [
            {
                "time": "2019-04-11",
                "original_text": "Novartis to Market Rizmoic Through Sandoz, Spins Off Alcon",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Rizmoic",
                        "Sandoz",
                        "Alcon"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-11",
                "original_text": "Biotechnology Market on a Tear: 5 ETFs in Spotlight",
                "features": {
                    "keywords": [
                        "Biotechnology",
                        "Market",
                        "ETFs"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-11",
                "original_text": "Top Research Reports for McDonald's, Enterprise Products & Charles Schwab",
                "features": {
                    "keywords": [
                        "McDonald's",
                        "Enterprise Products",
                        "Charles Schwab"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "consumer goods",
                        "energy",
                        "financial services"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-11",
                "original_text": "Intercept Reports Additional Positive Data From NASH Study",
                "features": {
                    "keywords": [
                        "Intercept",
                        "NASH",
                        "Study",
                        "Positive Data"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-11",
                "original_text": "Health Care Sector Update for 04/11/2019: AVGR, AUTL, NVS, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector",
                        "Update",
                        "AVGR",
                        "AUTL",
                        "NVS",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-11",
                "original_text": "Hereâ€™s the Real Problem with Altria Overpaying for CRON Stock",
                "features": {
                    "keywords": [
                        "Altria",
                        "CRON",
                        "Stock",
                        "Overpaying"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "tobacco",
                        "cannabis"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}